Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Pain 4Neoplasms 3Fatigue 3Pancreatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Polycystic Ovary Syndrome 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Depression 1Breast Neoplasms 1Anxiety Disorders 1Agnosia 1

Interventions

Doxorubicin 26Bleomycin 24Vinblastine 21Dacarbazine 20Vincristine 18Cyclophosphamide 16Radiotherapy 14Etoposide 13Prednisone 12Filgrastim 11ABVD protocol 10Procarbazine 8Peripheral Blood Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7Brentuximab Vedotin 6pegfilgrastim 5Methotrexate 5Dexamethasone 5Cytarabine 5Cyclosporine 5Prednisolone 4Mycophenolic Acid 4Mechlorethamine 4Cyclosporins 4Cisplatin 4Whole-Body Irradiation 3Vinorelbine 3Radiation 3Ifosfamide 3Epoetin Alfa 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hodgkin Disease × Acupuncture Therapy × Clear all
NCT04459416 2025-10-20

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
299 enrolled 11 charts
LymphoidPlasma cell

Agnosia, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡